scispace - formally typeset
E

Eva Mezey

Researcher at National Institutes of Health

Publications -  209
Citations -  24466

Eva Mezey is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Receptor & Bone marrow. The author has an hindex of 70, co-authored 205 publications receiving 23453 citations. Previous affiliations of Eva Mezey include Semmelweis University.

Papers
More filters
Journal ArticleDOI

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.

TL;DR: It is suggested that cultured, banked human BMSCs may be effective in treating sepsis in high-risk patient groups because they have been successfully given to humans and can easily be cultured and might be used without human leukocyte antigen matching.
Journal ArticleDOI

Turning Blood into Brain: Cells Bearing Neuronal Antigens Generated in Vivo from Bone Marrow

TL;DR: It is shown that, in a strain of mice incapable of developing cells of the myeloid and lymphoid lineages, transplanted adult bone marrow cells migrated into the brain and differentiated into cells that expressed neuron-specific antigens.
Journal ArticleDOI

The ubiquitin pathway in Parkinson's disease

TL;DR: It is shown that in a German family with Parkinson's disease a missense mutation in the ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene causes a partial loss of the catalytic activity of this thiol protease, which could lead to aberrations in the proteolytic pathway and aggregation of proteins.
Journal ArticleDOI

Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice

TL;DR: Results indicate that some microglia and astroglia arise from a precursor that is a normal constituent of adult bone marrow, and some bone marrow-derived cells surprisingly expressed the astroglial marker glial fibrillary acidic protein.
Journal ArticleDOI

Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human.

TL;DR: The finding that VR1 is expressed not only in primary sensory neurons but also in several brain nuclei is of great importance in that it places VRs in a much broader perspective than pain perception.